RRRebecca Robillard

Rebecca Robillard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rebecca Robillard has a total of 232 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association Between Sleep Changes and Symptom Recovery Following Pediatric Concussion

    by Paniz Tavakoli, Andree-Anne Ledoux, Keith Yeates, Ken Tang, Gurinder Sangha, Stephen B. Freedman, Jocelyn Gravel, Isabelle Gagnon, William Craig, Emma Burns, et al.

    Concussions are one of the most common causes of neurological morbidities in children. In addition to physical, cognitive, and emotional symptoms, a common complaint after concussion is the presence of sleep disturbances, such as trouble falling asleep. The present study sought to longitudinally assess the nature of sleep changes and their association with symptom recovery following concussion in a pediatric sample. Secondary analyses were conducted on a prospective, longitudinal, multicenter cohort study involving 2,991 children and adolescents (5–17 years) who presented to an emergency department within 48 h of a head trauma and who met diagnostic criteria for concussion consistent with the consensus statement prevailing at the time of data collection. Ratings of post-concussive symptoms and sleep disturbances were obtained at 5 pre-defined time points following concussion (weeks 1, 2, 4, 8, and 12), using the Post-Concussion Symptom Inventory (PCSI) and the sleep item of the Pediatric Quality of Life Inventory, respectively. Linear mixed models were fitted separately for the PCSI total score and the physical, cognitive, and emotional symptom subscales, adjusting for random participant effects. Model predictors included sleep, time, and time x sleep interaction. The model accounted for age, sex, maximum duration of previous concussion symptoms for individuals who had a previous concussion, prior diagnosis of developmental disorder, depression, and anxiety, and prior diagnosis of sleep disorders, as they are known risk factors for prolonged recovery. There was significant improvement in both sleep quality ratings (mean values per time point: week 1 = 76.3, SD = 30.1; week 2 = 81.6, SD = 28; week 4 = 82.4, SD = 27.4; week 8 = 86.6, SD = 24.2; week 12 = 89, SD = 22.8) and post-concussive symptoms across time points (mean delta values per time point: week 1 = 0.40, SD = 0.77; week 2 = 0.39, SD = 0.76; week 4 = 0.38, SD = 0.76; week 8 = 0.38, SD = 0.76; week 12 = 0.38, SD = 0.76) (all p < 0.001). Significant sleep*time interactions showed that better sleep was significantly associated with reduced global (β = 0.003, p = 0.030, 95% CI [0.00003, 0.0006]) and physical post-concussion symptoms (β = 0.007, p = 0.035, 95% CI [0.0005, 0.01]) after the injury relative to pre-injury levels, especially in early phases of recovery. Better sleep, regardless of the recovery period, was associated with greater reductions in patient-reported cognitive (β = −0.26, p = 0.0001, 95% CI [−0.34, −0.18]) and emotional symptoms (β = −0.28, p = 0.0001, 95% CI [−0.35, −0.20]) after concussion. The present findings indicate that better sleep is linked to more favorable post-concussion recovery as reflected by different clusters of symptoms. These results highlight the importance of investigating whether safeguarding sleep in children and adolescents with concussion may facilitate recovery.

  • Open Access

    Sociodemographic and health correlates of reimbursement authorizations for cannabis for medical purposes in Canadian veterans: A cross-sectional study linking the Life After Services Studies 2019 and Health Administrative Databases

    by Tetyana Kendzerska, Julián Reyes, Noah Poirier, Alain Poirier, Alex Cull, Anthony Murkar, Mouaz Saymeh, Stephanie Belanger, Monnica Williams, Jakov Shlik, et al.

    Background: Evidence on factors associated with cannabis for medical purposes (CMP) authorizations among Veterans Affairs Canada (VAC) clients remains limited and inconsistent, particularly concerning mental health and posttraumatic stress disorder (PTSD), a leading indication for use. We investigated demographic, clinical and service characteristics associated with VAC authorizations for CMP reimbursement. Method: We linked VAC administrative CMP program data with responses from the 2019 Life After Services Studies cross-sectional survey of Regular Force veterans released between 1998 and 2018. Multivariable logistic regressions examined associations between CMP reimbursement (yes/no) and demographic, clinical and well-being factors, with analyses stratified by PTSD status. Results: Among 1,289 respondents (weighted n=33,131), 18.4% were authorized for CMP reimbursement. Younger age (<40 vs. ≥60 years: OR 4.78, 95% CI: 2.24–10.21), unemployment with inability to work vs. employed (OR 3.10, 95% CI: 1.78–5.40), land service vs. air (OR 2.07, 95% CI: 1.22–3.50), PTSD (OR 2.81, 95% CI: 1.69–4.66), anxiety (OR 2.32, 95% CI: 1.45–3.70), and severe pain vs. no pain (OR 3.61, 95% CI: 1.97–6.60) were independently associated with authorization. Unemployment and severe pain were consistent correlates across PTSD strata. Among those without PTSD, younger age, multiple physical conditions, and frequent mental health visits were significant; among those with PTSD, shorter service, witnessing destruction, and suicidal ideation were additional factors. Conclusions: CMP authorization patterns among Canadian veterans reflect the intersection of mental health, pain, and functional impairment, with variation by PTSD status. These findings underscore the need for longitudinal research on CMP mechanisms, effectiveness and safety.

  • Open Access

    Assessing the performance of a portable electroencephalographic sleep monitor against level 1 polysomnography

    by Malika Lanthier, Karina Fonseca, Caitlin Higginson, Defne Oksit, David Smith, Jean-Marc Lina, Paniz Tavakoli, Stuart Fogel, Laura Ray, Rébecca Robillard, et al.

    Study Objectives: To assess the performance of a portable electroencephalography device for sleep monitoring against polysomnography. Method: Fifty-six adults underwent one night of in-laboratory sleep recording with the Muse-S headband and simultaneous level 1 polysomnography. Muse-S data were scored by an automated sleep staging algorithm. A registered technologist, blind to the Muse-S automated sleep scoring, scored the polysomnography data. Results: Good quality data were available for 47 (84 per cent) participants (53 per cent females; 20–71 years old; 17 per cent with sleep-related breathing disorder). Epoch-by-epoch analyses showed substantial agreement between the Muse-S and polysomnography (full night Cohen’s Kappa = 0.76). Cohen’s Kappa were in the fair agreement range for non-rapid eye movement (NREM) 1, substantial agreement range for NREM2 and NREM3, and near-perfect agreement range for rapid eye movement sleep and wake. Accuracy ranged from 88 per cent to 96 per cent across all sleep stages, with a sensitivity of 79–92 per cent and a specificity of 90–99 per cent. Similar results were observed in the subgroup with sleep-related breathing disorder. On average, the Muse-S had higher mean values than polysomnography for total sleep time (+6 min), NREM3 (+15 min), rapid eye movement sleep (+6 min), and sleep efficiency (+1.5 per cent), and lower mean values for sleep latency (−3 min), wake after sleep onset (−3 min), and light sleep (−14 min). Conclusions: When compared to standard polysomnography, the Muse-S performed well to measure sleep macroarchitecture. This portable device shows great potential as an accessible tool for sleep electroencephalography monitoring. More work is required to validate this tool in more diverse populations to ensure robustness across age, sex, neurological conditions, and sleep profiles. This article is part of the Consumer Sleep Technology Special Collection Statement of Significance Most portable monitors are restricted to indirect measures to estimate sleep. This study offers an independent assessment of the performance of a portable electroencephalography headband. Compared to in-laboratory polysomnography, this type of device enables more accessible multi-night data collection in the natural sleeping environment. Such technologies have tremendous potential to expand research capacity and clinical applications. This article may help to inform the choice of appropriate technologies to be used to address specific research questions and to anticipate the strengths and limitations of this new technology.


  • Open Access

    Sleep, Health Care–Seeking Behaviors, and Perceptions Associated With the Use of Sleep Wearables in Canada: Results From a Nationally Representative Survey

    by Karianne Dion, Meggan Porteous, Tetyana Kendzerska, Ashley Nixon, Elliott Lee, Massimiliano de Zambotti, Sheila N Garland, Mandeep Singh, Gino De Luca, Samuel Gillman, et al.

    Background: The popularity of sleep-tracking wearables has surged worldwide. Yet, there are significant gaps in understanding the real-life implications of this phenomenon. While wearables may offer insights about sleep and promote sleep health awareness, evidence remains mixed on whether they lead to improved sleep outcomes or fuel sleep anxiety. Objective: This study aims to (1) determine the prevalence and sociodemographic predictors of using sleep wearables in Canada, (2) evaluate the perceived effects of wearable use on sleep and stress, (3) compare sleep and health care–seeking behaviors in users and nonusers, and (4) investigate the moderating effects of wearable use on the association between sleep and anxiety. Methods: An online survey investigating sleep and mental health was distributed to a representative sample of 1200 Canadians. The survey included questions on demographics, wearables use, sleep patterns, health care–seeking behaviors, insomnia (ISI-3 [Insomnia Severity Index-3]), and anxiety (GAD-7 [Generalized Anxiety Disorder-7]) symptoms. Analyses relied on descriptive statistics and logistic regression (aims 1 and 2), multivariate analyses of covariance and chi-squared analyses (aim 3), and multiple regression (aim 4). Results: Among the 1200 respondents (n=636, 53% female; aged 16 to 88 years), 19.3% (n=231) reported using a wearable device to monitor sleep. Several sociodemographic variables were associated with an increased likelihood of using wearables including: youth, being retired, being part of a racialized minority group, earning a higher income, having greater health care coverage, having a sleep disorder, and having a mental disorder (χ214=110.2, P<.001). Of all wearable users, nearly 45% felt that using sleep wearables had a positive effect on their sleep (n=102) and stress levels (n=97), while 4.5% (n=10) noted a negative effect. Compared to nonusers, wearable users reported 13 minutes longer sleep onset latency (F1,1151=5.21, P=.02, ƞp2=0.005), slept about 1 hour less (F1,1143=31.60, P<.001, ƞp2=0.027), and endorsed more severe insomnia symptoms (F1,1119=4.04, P<.05, ƞp2=0.004). After adjusting for the presence of sleep disorders, only the differences in sleep duration remained. The proportion of wearable users was almost twice as high in those having informed a health care provider about sleep difficulties (χ22=35.4, P<.001) and in those having used sleep medications (χ23=38.7, P<.001). Wearable use was identified as a moderator of the effect of anxiety symptoms on sleep duration, with wearable users showing a steeper decline in total sleep time as anxiety increased compared to nonusers (F1,1165=17.5, P<.001). Conclusions: One in 5 Canadians acknowledged having used sleep wearables. Predictors include younger age, higher income, and having a sleep or mental disorder. Although many individuals reported positive effects of sleep wearables, wearables use strengthened the link between short sleep and anxiety. Expanding our understanding of the factors associated with beneficial versus detrimental use of sleep wearables may help support more informed applications.


  • Open Access

    Sleep Stage Classification using Multimodal Embedding Fusion from EOG and PSM

    by Olivier Papillon, Rafik Goubran, James Green, Julien Larivière-Chartier, Caitlin Higginson, Frank Knoefel, Rébecca Robillard

    Accurate sleep stage classification is essential for diagnosing sleep disorders, particularly in aging populations. While traditional polysomnography (PSG) relies on electroencephalography (EEG) as the gold standard, its complexity and need for specialized equipment make home-based sleep monitoring challenging. To address this limitation, we investigate the use of electrooculography (EOG) and pressure-sensitive mats (PSM) as less obtrusive alternatives for five-stage sleep-wake classification. This study introduces a novel approach that leverages ImageBind, a multimodal embedding deep learning model, to integrate PSM data with dual-channel EOG signals for sleep stage classification. Our method is the first reported approach that fuses PSM and EOG data for sleep stage classification with ImageBind. Our results demonstrate that fine-tuning ImageBind significantly improves classification accuracy, outperforming existing models based on single-channel EOG (DeepSleepNet), exclusively PSM data (ViViT), and other multimodal deep learning approaches (MBT). Notably, the model also achieved strong performance without fine-tuning, highlighting its adaptability to specific tasks with limited labeled data, making it particularly advantageous for medical applications. We evaluated our method using 85 nights of patient recordings from a sleep clinic. Our findings suggest that pre-trained multimodal embedding models, even those originally developed for non-medical domains, can be effectively adapted for sleep staging, with accuracies approaching systems that require complex EEG data.

  • Open Access

    Sleep Position Classification using Transfer Learning for Bed-based Pressure Sensors

    by Olivier Papillon, Rafik Goubran, James Green, Julien Larivière-Chartier, Caitlin Higginson, Frank Knoefel, Rébecca Robillard

    Bed-based pressure-sensitive mats (PSMs) offer a non-intrusive way of monitoring patients during sleep. We focus on four-way sleep position classification using data collected from a PSM placed under a mattress in a sleep clinic. Sleep positions can affect sleep quality and the prevalence of sleep disorders, such as apnea. Measurements were performed on patients with suspected sleep disorders referred for assessments at a sleep clinic. Training deep learning models can be challenging in clinical settings due to the need for large amounts of labeled data. To overcome the shortage of labeled training data, we utilize transfer learning to adapt pre-trained deep learning models to accurately estimate sleep positions from a low-resolution PSM dataset collected in a polysomnography sleep lab. Our approach leverages Vision Transformer models pre-trained on ImageNet using masked autoencoding (ViTMAE) and a pre-trained model for human pose estimation (ViTPose). These approaches outperform previous work from PSM-based sleep pose classification using deep learning (TCN) as well as traditional machine learning models (SVM, XGBoost, Random Forest) that use engineered features. We evaluate the performance of sleep position classification from 112 nights of patient recordings and validate it on a higher resolution 13-patient dataset. Despite the challenges of differentiating between sleep positions from low-resolution PSM data, our approach shows promise for real-world deployment in clinical settings


  • Open Access

    TRANSCENDENT (Transforming Research by Assessing Neuroinformatics across the Spectrum of Concussion by Embedding iNterdisciplinary Data-collection to Enable Novel Treatments): protocol for a prospective observational cohort study of concussion patients with embedded comparative effectiveness research within a network of learning health system concussion clinics in Canada

    by Roger Zemek, Lisa M Albrecht, Sharon Johnston, John Leddy, Andrée-Anne Ledoux, Nick Reed, Noah Silverberg, Keith Yeates, Monica Lamoureux, Charlotte Anderson, et al.

    Introduction Concussion affects over 400 000 Canadians annually, with a range of causes and impacts on health-related quality of life. Research to date has disproportionately focused on athletes, military personnel and level I trauma centre patients, and may not be applicable to the broader community. The TRANSCENDENT Concussion Research Program aims to address patient- and clinician-identified research priorities, through the integration of clinical data from patients of all ages and injury mechanisms, patient-reported outcomes and objective biomarkers across factors of intersectionality. Seeking guidance from our Community Advisory Committee will ensure meaningful patient partnership and research findings that are relevant to the wider concussion community. Methods and analysis This prospective observational cohort study will recruit 5500 participants over 5 years from three 360 Concussion Care clinic locations across Ontario, Canada, with a subset of participants enrolling in specific objective assessments including testing of autonomic function, exercise tolerance, vision, advanced neuroimaging and fluid biomarkers. Analysis will be predicated on pre-specified research questions, and data shared with the Ontario Brain Institute’s Brain-CODE database. This work will represent one of the largest concussion databases to date, and by sharing it, we will advance the field of concussion and prevent siloing within brain health research. Ethics and dissemination This study was approved by the Children’s Hospital of Eastern Ontario Research Ethics Board and preregistered on OSF (25 June 2024); https://doi.org/10.17605/OSF.IO/HYDZC. Dissemination of findings will be multifaceted, including conference presentations, peer-reviewed publications and sharing of adapted materials (eg, videos, infographics, plain language summaries) with community groups and key knowledge users.


  • Open Access

    Association of nocturnal hypoxemia and white blood cell count in a multicenter cohort

    by Aditi Shah, Mohammadreza Hajipour, A J Hirsch Allen, Najib Ayas, Tetyana Kendzerska, Patrick Hanly, John Kimoff, Frederic Series, Annie Lajoie, Rebecca Robillard, et al.

    Study Objectives: There is a higher risk of cardiovascular disease (CVD) in patients with obstructive sleep apnea (OSA) and innate immunity is a potential pathophysiologic pathway. The objective of this study was to determine whether nocturnal hypoxemia is associated with circulating markers of innate immunity in OSA. Methods: This was a cross-sectional study of an observational cohort from the multicentre, clinic-based, Canadian Sleep and Circadian Network. Oxygen desaturation index 4% (ODI4%) was used to diagnose and determine the severity of OSA. The percentage of time spent below SpO2 <90% (T90) and minimum SpO2 we considered as other measures of nocturnal hypoxemia. Multiple linear regressions were used to assess associations between total white blood cell (WBC) and subsets and ODI and hypoxemia indices. Results: A total of 1296 patients were included in the analysis. There was a positive association between ODI4% and lymphocyte count, adjusting for confounders. For every 1-SD increase in ODI4%, lymphocyte counts increased by 0.08 × 109 L (95% CI 0.01 to 0.15) SD. Patients with severe OSA (ODI4% ≥ 30 events/hour) had significantly higher total WBC and lymphocyte count than non-OSA cohort, in the adjusted model, p-value <.02, for both. There was a positive association between T90 and total WBC, neutrophil, lymphocyte, and monocyte count, adjusting for confounders. Minimum SpO2 was independently associated with total WBC, neutrophil, and monocyte counts. Conclusions: In this pan-Canadian clinic-based cohort of individuals with suspected OSA, nocturnal hypoxemia indices were associated with an increase in total WBC and subset counts.